What is the most recent earnings date for BCYC stock?
BICYCLE THERAPEUTICS PLC-ADR (BCYC) last reported earnings on 3/17/2026.
BICYCLE THERAPEUTICS PLC-ADR (BCYC) Earnings History & Surprises
NASDAQ:BCYC • US0887861088
Current stock price
5.05 USD
+0.15 (+3.06%)
At close:
5.0011 USD
-0.05 (-0.97%)
After Hours:
BCYC Earnings overview
Past quarterly earnings results for BICYCLE THERAPEUTICS PLC-ADR (BCYC), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Apr 29, 2026
- Period
- Q1 / 2026
- EPS Estimate
- -$0.69
- Revenue Estimate
- 8.963M
Last Reported
Most Recent- Release Date
- Mar 17, 2026
- Period
- Q4 / 2025
- EPS Reported
- -$0.29
- EPS Surprise
- 69.66%
- Revenue Surprise
- 564.66%
Beat Rate
Last 8 Quarters 69%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.29 | -0.96 | 69.66% | 64.63% | 47.955M | 7.215M | 564.66% | 1,193.28% |
| Q3 2025 | -0.85 | -1.10 | 22.68% | -14.86% | 11.734M | 7.48M | 56.87% | 338.49% |
| Q2 2025 | -1.14 | -0.97 | -17.46% | -48.05% | 2.92M | 8.888M | -67.15% | -68.81% |
| Q1 2025 | -0.88 | -0.86 | -2.43% | -41.94% | 9.977M | 7.939M | 25.67% | -48.91% |
| Q4 2024 | -0.82 | -0.88 | 6.37% | 29.31% | 3.708M | 5.541M | -33.08% | -30.44% |
| Q3 2024 | -0.74 | -0.80 | 7.19% | 41.27% | 2.676M | 6.975M | -61.63% | -50.00% |
| Q2 2024 | -0.77 | -1.12 | 31.27% | 45.39% | 9.361M | 6.289M | 48.85% | -17.86% |
| Q1 2024 | -0.62 | -1.27 | 51.12% | 52.31% | 19.53M | 6.15M | 217.56% | 298.90% |
| Q4 2023 | -1.16 | -1.26 | 7.79% | -14.85% | 5.331M | 7.278M | -26.75% | 67.12% |
| Q3 2023 | -1.26 | -1.19 | -5.45% | -31.25% | 5.352M | 13.35M | -59.91% | 76.05% |
| Q2 2023 | -1.41 | -1.32 | -6.88% | -56.67% | 11.397M | 4.676M | 143.73% | 160.21% |
| Q1 2023 | -1.30 | -1.09 | -18.77% | -39.78% | 4.896M | 3.959M | 23.67% | 26.84% |
| Q4 2022 | -1.01 | -1.08 | 6.47% | -60.32% | 3.19M | 3.964M | -19.53% | -15.38% |
| Q3 2022 | -0.96 | -0.91 | -5.91% | -62.71% | 3.04M | 5.576M | -45.48% | -29.79% |
| Q2 2022 | -0.90 | -0.87 | -3.98% | -21.62% | 4.38M | 3.787M | 15.66% | 144.69% |
| Q1 2022 | -0.93 | -0.70 | -33.75% | -27.40% | 3.86M | 4.499M | -14.20% | 113.26% |
| Q4 2021 | -0.63 | -0.62 | -1.13% | 24.10% | 3.77M | 5.417M | -30.40% | -2.08% |
| Q3 2021 | -0.59 | -0.62 | 5.39% | -13.46% | 4.33M | 4.521M | -4.22% | 12.76% |
| Q2 2021 | -0.74 | -0.74 | 0.10% | -10.45% | 1.79M | 2.354M | -23.96% | 14.01% |
| Q1 2021 | -0.73 | -0.72 | -1.28% | -15.87% | 1.81M | 1.844M | -1.84% | 60.18% |
| Q4 2020 | -0.83 | -0.48 | -72.22% | - | 3.85M | 4.071M | -5.43% | - |
| Q3 2020 | -0.52 | -0.53 | 1.49% | - | 3.84M | 3.177M | 20.87% | - |
| Q2 2020 | -0.67 | -0.49 | -38.08% | - | 1.57M | 2.922M | -46.27% | - |
| Q1 2020 | -0.63 | 0.11 | -661.50% | - | 1.13M | 10.561M | -89.30% | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
18.11%
Max EPS beat (4)
69.66%
Min EPS beat (4)
-17.46%
Revenue beat statistics
Revenue beat (4)
3
Average Revenue beat (4)
145.01%
Max Revenue beat (4)
564.66%
Min Revenue beat (4)
-67.15%
Analysis
In the last 4 quarters, BCYC has beaten EPS estimates in 2 out of 4 releases
BCYC has beaten revenue estimates in 3 out of the last 4 releases
In the last 4 quarters, BCYC has beaten the EPS estimates by 18.1% on average.
In the last 4 quarters, BCYC has beaten the revenue estimates by 145.0% on average.
Related analysis
BICYCLE THERAPEUTICS PLC-ADR / BCYC Earnings FAQ
Can you provide information on whether BICYCLE THERAPEUTICS PLC-ADR beat earnings estimates in the last quarter?
BICYCLE THERAPEUTICS PLC-ADR (BCYC) beat EPS estimates and beat revenue estimates in the most recent quarter.
How often does BICYCLE THERAPEUTICS PLC-ADR (BCYC) beat earnings estimates?
In the last 4 quarters, BICYCLE THERAPEUTICS PLC-ADR (BCYC) has beaten EPS estimates in 2 out of 4 releases.